Bronchial Cough Therapy
Active substance: SPONGIA OFFICINALIS SKELETON, ROASTED, ANTIMONY POTASSIUM TARTRATE, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, ECHINACEA, UNSPECIFIED, CALCIUM SULFIDE, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED
TABLET, ORALLY DISINTEGRATING · SPONGIA OFFICINALIS SKELETON, ROASTED 6 [hp_C]/1, ANTIMONY POTASSIUM TARTRATE 6 [hp_C]/1, PROTORTONIA CACTI 6 [hp_C]/1, DROSERA ROTUNDIFOLIA 6 [hp_C]/1, ECHINACEA, UNSPECIFIED 6 [hp_C]/1, CALCIUM SULFIDE 6 [hp_C]/1, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED 18 [hp_C]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SPONGIA OFFICINALIS SKELETON, ROASTED · 6 [hp_C]/1
- ANTIMONY POTASSIUM TARTRATE · 6 [hp_C]/1
- PROTORTONIA CACTI · 6 [hp_C]/1
- DROSERA ROTUNDIFOLIA · 6 [hp_C]/1
- ECHINACEA, UNSPECIFIED · 6 [hp_C]/1
- CALCIUM SULFIDE · 6 [hp_C]/1
- HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED · 18 [hp_C]/1
Registration
- Registration number
- 17312-018
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-018 · Verified 2026-10-09 · open in source